A Report by the American Academy of Ophthalmology
Ophthalmic Technology Assessment Committee Cornea and Anterior Segment Disorders Panel: W. Barry Lee, MD; Deborah S. Jacobs, MD; David C. Musch, PhD, MPH; Stephen C. Kaufman, MD, PhD; William J. Reinhart, MD; Roni M. Shtein, MD
Published in Ophthalmology, September 2009, Vol. 116, 1818-1830
- Evidence-based summary of safety and outcomes for DSEK/DSAEK
- Most common complications:
- Posterior graft dislocations
- Endothelial graft rejection
- Primary graft failure
- Iatrogenic glaucoma
- Average BCVA from 20/34 to 20/66 (mean, 9 months)
- Evidence supports DSEK as a safe and effective treatment for corneal endothelial diseases
